Cargando…
O049 Insomnia severity and cognitive performance following two weeks’ nightly supplementation with 150mg Cannabidiol (CBD) for primary insomnia
INTRODUCTION: Cannabidiol (CBD) may have sleep promoting effects, but clinical dosage and safety recommendations are still lacking. This study was the first to examine whether the approved Therapeutic Goods Association (TGA) daily over-the-counter maximum dose of oral CBD oil (150mg) improved the se...
Autores principales: | Narayan, A, Downey, L, Hayley, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109312/ http://dx.doi.org/10.1093/sleepadvances/zpac029.048 |
Ejemplares similares
-
Cannabidiol (CBD) and Insomnia : Literature review
por: Gutierrez Higueras, T., et al.
Publicado: (2022) -
O006 Acute effects of combined cannabidiol (CBD) and ∆9-tetrahydrocannabinol (THC) in insomnia disorder: A randomised, placebo-controlled trial using high-density EEG
por: Suraev, A, et al.
Publicado: (2022) -
P049 Barriers and facilitators to the delivery of insomnia management by general practice nurses: a qualitative analysis of patient perspectives
por: Grivell, N, et al.
Publicado: (2022) -
O049 Sleep quality and its impact on children with primary ciliary dyskinesia
por: Ewert, I, et al.
Publicado: (2021) -
O001 Providing feedback and guidance on sleep perceptions using sleep wearables improves insomnia: Findings from the randomised Novel Insomnia Treatment Experiment (“NITE”)
por: Spina, M, et al.
Publicado: (2022)